Ana sayfa
Piyasalar
Grafikler ve fikirler
Algo
Haberler
Store
Aracı kurumlar
İndir
Ekonomik Takvim
Alım-satım sinyalleri
Web Terminali
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
NRIX
#1905
Nurix Therapeutics, Inc. Common stock
15.970
0
+2.70%
Sektör:
Baz:
Kar para birimi:
Günlük aralık
Yıllık aralık
Günlük değişim
+2.70%
Aylık değişim
-18.42%
6 aylık değişim
+42.46%
Yıllık değişim
+42.46%
Önceki kapanış
15.550
0
Open
15.970
0
Bid
Ask
Low
15.970
0
High
15.970
0
Hacim
162
Piyasalar
ABD hisse senetleri
Sağlık hizmetleri
NRIX
Open full chart
Financials
Overview
Rapor
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
38.91 M
44.74 M
47.27 M
48.89 M
75.89 M
102.84 M
—
Valuation ratios
Enterprise value
1.54 B
1.21 B
521.24 M
249.49 M
1.52 B
1.49 B
4.06 B
Price to earnings ratio
—
—
-3.34
-2.35
-7.46
-5.54
-18.83
Price to sales ratio
—
—
15.59
4.39
26.44
17.45
56.77
Price to cash flow ratio
—
—
3.77
4.15
8.36
5.87
19.16
Price to book ratio
—
—
1.98
1.69
2.74
2.72
4.24
Enterprise value to EBITDA ratio
—
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.11
0.25
0.43
0.4
0.29
0.38
0.44
Return on equity %
0.15
0.34
0.59
0.72
0.37
0.49
0.59
Return on invested capital %
132.86
270.56
403.07
629.36
713.83
923.04
904.34
Gross margin %
100
100
100
100
100
100
400
Operating margin %
364.66
396.26
476.01
201.41
390.52
340.16
2 220.03
EBITDA margin %
—
—
—
—
—
—
—
Net margin %
242.66
393.93
466.93
186.98
354.85
314.9
2 074.93
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
6.7
4.7
4.51
3.4
6.46
7.02
25.45
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.04
0.07
0.09
0.2
0.11
0.12
0.14
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
—
3.29
1.5
2.57
2.88
2.95
EBIT per share
—
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
—
6.36
5.3
9.08
6.84
24.31
Net current asset value per share
—
—
6.55
5.44
9.23
7
25.13
Tangible book value per share
—
—
6.25
3.69
7.85
6.22
21.73
Working capital per share
—
—
5.1
3.84
7.8
6
21.17
Book value per share
—
—
6.25
3.69
7.85
6.22
21.73
Haberler
Nurix Therapeutics Stock Sees RS Rating Jump To 82
Nurix’in hukuk müdürü Ring Christine, NRIX hisselerinde 237 bin dolar satış yaptı
Nurix Therapeutics CFO Hans van Houte sells $61k in shares
Nurix Therapeutics chief legal officer Ring sells $73k in stock
Nurix Therapeutics CSO’su Gwenn Hansen 81 bin dolarlık hisse satışı gerçekleştirdi
Nurix Therapeutics CSO Gwenn Hansen sells $81k in shares
Stifel, bexobrutideg potansiyeli nedeniyle Nurix hisse fiyat hedefini 35 dolara yükseltti
Stifel raises Nurix stock price target to $35 on bexobrutideg potential
Piper Sandler, Nurix hisse fiyat hedefini önemli deneme planları nedeniyle 35 dolara yükseltti
Piper Sandler raises Nurix stock price target to $35 on pivotal trial plans
H.C. Wainwright, finansal sonuçlar sonrası Nurix hisse fiyat hedefini 32 dolara yükseltti
H.C. Wainwright raises Nurix stock price target to $32 on financial results